[NDRA] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[NDRA] ENDRA Life Sciences Inc.
Announcement Date
08-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- 15.10%
YoY- -26.37%
Quarter Report
NDRA's Result
NDRA's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 0 0 0 0 0 58 0 -
PBT -3,591 -3,199 -2,894 -2,334 -1,847 -1,432 -729 30.42%
Tax 19 1 5 0 -0 0 0 -
NP -3,610 -3,199 -2,894 -2,334 -1,847 -1,432 -729 30.54%
Tax Rate - - - - - - - -
Total Cost 3,610 3,199 2,894 2,334 1,847 1,490 729 30.54%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -2,478.35 0.00 -
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -1.17 -1.54 -3.93 -6.29 -9.42 -11.75 -3.73 -17.56%
EPS Diluted -1.17 -1.54 -3.93 -6.29 -9.42 -11.75 -3.73 -17.56%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.